Verve Therapeutics Inc. (VERV)
undefined
undefined%
At close: undefined
5.81
1.57%
After-hours Dec 13, 2024, 06:09 PM EST

Verve Therapeutics Inc. Forcast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for VERV stock have an median target of 24.5, with a low estimate of 14 and a high estimate of 40. The median target predicts an increase of 328.32% from the current stock price of 5.72.

Analyst Consensus: Buy
Target Low Average Median High
Price $14 $25.75 $24.5 $40
Change 144.76% 350.17% 328.32% 599.30%

AI Analyst Report

RBC Capital has reaffirmed its Outperform rating f... Unlock content with Pro Subscription

Updated Nov 06, 2024

Rating Feb 24Apr 24May 24Aug 24Nov 24
Strong Buy 00001
Buy 11132
Hold 00000
Sell 00000
Strong Sell 00000
Total 1 1 1 3 3

Financial Forecast this Year

Revenue This Year
18.14M
from 11.76M
Increased by 54.3%
Revenue Next Year
13.40M
from 18.14M
Increased by -26.1%
EPS This Year
-2.58
from -3.12
Increased by 17.3%
EPS Next Year
-2.84
from -2.58
Increased by -10.1%